Navigation Links
Metformin may lower cancer risk in people with Type 2 diabetes
Date:6/25/2012

A commonly prescribed diabetes drug, metformin, reduces the overall cancer risk in people with Type 2 diabetes, a large systematic review study finds. The results will be presented Monday at The Endocrine Society's 94th Annual Meeting in Houston.

"Type 2 diabetes increases the risk for several types of cancer," said lead author Diego Espinoza-Peralta, MD, an endocrinologist with Mexico's National Institute of Medical Sciences and Nutrition (Instituto Nacional de Ciencias Medicas y Nutricion) in Mexico City. "Our findings suggest that the regular use of metformina low-cost medication reduces this risk, compared with not taking metformin."

Espinoza-Peralta and his colleagues conducted a systematic review and meta-analysis, or combined statistical analysis, of reported studies that evaluated cancer risk in patients with Type 2 diabetes. They analyzed seven relevant studies that included more than 32,400 Type 2 diabetic patients who had no other known condition that increased their cancer risk.

The investigators found that the odds of getting any type of cancer was 0.62 times lessan estimated 38 percent relative risk reductionwith daily continuous use of metformin than for those with no exposure to metformin.

"This risk reduction with metformin use extended to certain types of cancers, specifically colon and breast cancer," Espinoza-Peralta said.

Colorectal cancer and breast cancer are among the cancers that studies have found to occur more often in people with Type 2 diabetes. There was no risk reduction, however, in pancreatic cancer, another type of cancer for which people with Type 2 diabetes are at increased risk, the authors reported.

Metformin, which is the standard recommended initial treatment of Type 2 diabetes, may protect against cancer because it regulates activity of an enzyme that suppresses cell growth, according to Espinoza-Peralta.

"There is growing evidence that metformin brings more benefits to diabetic patients beyond glucose control," he said.


'/>"/>

Contact: Aaron Lohr
alohr@endo-society.org
240-482-1380
The Endocrine Society
Source:Eurekalert

Related medicine news :

1. Value of Metformin, Insulin Combo for Type 2 Diabetes Questioned
2. Metformin Outperforms Common Class of Diabetes Drugs in Study
3. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
4. Tree nut consumption associated with lower body weight and lower prevalence of health risks
5. Diagnostic yield of colonoscopy for melena after nondiagnostic upper endoscopy is lower than previously reported
6. Everyday Activities Might Lower Alzheimers Risk
7. Modest alcohol consumption lowers risk and severity of liver disease
8. Lower Risk for Bowel Obstruction With Less Invasive Surgery: Study
9. CAM therapy combined with conventional medical care may improve treatment of lower back pain
10. Blood pressure drugs linked with lower PTSD symptoms
11. Lower-Dose Radioiodine Effective Against Thyroid Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... , ... March 27, 2017 , ... Buzzies parent company, ... 10 for Rent the Runway Foundation and UBS’ Project Entrepreneur. Mayo will present her ... April 8. , Project Entrepreneur’s second annual venture competition ignites bold ideas by ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... recently received the CE Certificate of Conformity for the Smart System® 20/20. CE ... exceed the highest industry standards and specifications such as ANSI, ISO and proven ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... and conference coverage on veterinary medicine, announces the launch of Veterinarian’s Money Digest™, ... packaged with the April edition of American Veterinarian™. , “We look ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... weight management program at Women’s Excellence will help patients lose weight and keep ... exam. The specialists at Women's Excellence will measure BMI, body fat composition, ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... epigenetic research products enables researchers to pursue the recent RNA methylation “gold rush” ... . In light of the newfound characteristics of N6-methyladenosine, or m6A , ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... India , March 24, 2017 Abdominal Aortic Aneurysm Repair ... million by 2022, Globally, registering a CAGR of 5.1% from 2016 to 2022. The ... projected to dominate the market during the study period. ... ... ...
(Date:3/24/2017)... , March 24, 2017 New England Pediatric ... of an award including funding and in-kind service towards ... technology.  "Making blood draws less traumatic ... their whole hospital experience better.  We,re looking forward to ... can help improve care for the kids we treat," ...
(Date:3/24/2017)... 2017 Research and Markets has announced the addition ... Demand Forecast to 2022" report to their offering. ... The global wound care market was worth ... CAGR of 6.7% during 2016-2022 Among the various wound care ... in the global market in 2015. Among the various applications, surgical wound ...
Breaking Medicine Technology: